Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2002
04/24/2002CN1083438C Substituted dismino-1,3,5-triazine derivatives
04/24/2002CN1083431C Novel heterocyclic compounds
04/23/2002US6376670 Bactericide for grampositive bacteria
04/23/2002US6376538 Antiinflammatory agents; autoimmune diseases
04/23/2002US6376535 Oxygen-containing heterocyclic compounds
04/23/2002US6376527 Pyrazole derivatives-p38 map kinase inhibitors
04/23/2002US6376520 Pesticides
04/23/2002US6376518 Anticarcinogenic agents; side effect reduction
04/23/2002US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?)
04/23/2002US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases
04/23/2002US6376503 Alpha 1a adrenergic receptor antagonists
04/23/2002US6376499 Piperazine-amide compound with anticoagulant activity
04/23/2002US6376497 Excellent, wide-spectrum antifungal activities and low toxicity
04/23/2002US6376491 Benzofuran derivatives for treatment or prevention of mycosis in mammals
04/23/2002CA2263353C Arylsulfonylimidazolone derivatives as an antitumor agent
04/23/2002CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
04/23/2002CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds
04/23/2002CA2069144C Imidazole compounds, their preparation and use
04/20/2002CA2359383A1 Use of pdev inhibitors for improved fecundity in mammals
04/18/2002WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002WO2002030926A1 Quinazoline derivatives
04/18/2002WO2002030925A1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them
04/18/2002WO2002030924A1 Quinazoline derivatives with anti-tumour activity
04/18/2002WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002WO2002030922A2 Dioxolane analogs for improved inter-cellular delivery
04/18/2002WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS
04/18/2002WO2002030894A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
04/18/2002WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors
04/18/2002WO2002030890A1 Nitrogenous five-membered ring compounds
04/18/2002WO2002030462A2 Hedgehog antagonists, methods and uses related thereto
04/18/2002WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
04/18/2002WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/18/2002WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors
04/18/2002WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/18/2002WO2001015656A9 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents
04/18/2002US20020045757 Compound and process for producing beta-adrenergic receptor agonist
04/18/2002US20020045756 Preparation of camptothecin and of its derivatives
04/18/2002US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof.
04/18/2002US20020045752 Method for reducing an organic solvent remaining in beta-form tris- (2,3,-epoxypropyl) - isocyanurate crystals
04/18/2002US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
04/18/2002US20020045645 Lactone integrin antagonists
04/18/2002US20020045644 2-phenylpyran-4-one derivatives
04/18/2002US20020045628 Antidepressants; anxiolytic agents; serotonin-affected nervous system disorders; acting at the 5-HT1a autoreceptors concommitantly with 5-HT transporters; antiserotonin agents; serotonin reuptake inhibitors; HT3 receptor antagonists
04/18/2002US20020045619 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
04/18/2002US20020045618 Heteroaryl diazacycloalkanes, their preparation and use
04/18/2002US20020045616 Lactam inhibitors of FXa and method
04/18/2002US20020045614 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders
04/18/2002US20020045613 1-aroyl-piperidinyl benzamidines
04/18/2002US20020045228 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
04/18/2002US20020044909 Cyanine dye bioconjugates with bioactive molecules for diagnosis and therapy, particularly for visualization and detection of tumors
04/18/2002US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates
04/18/2002DE10047116A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines
04/18/2002CA2459746A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents
04/18/2002CA2425416A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002CA2425359A1 Dioxolane analogs for improved inter-cellular delivery
04/18/2002CA2425356A1 Hedgehog antagonists, methods and uses related thereto
04/18/2002CA2424802A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/17/2002EP1197504A1 Thermoplastic polymer having polar group, use thereof, and unsaturated compounds having polar group
04/17/2002EP1197485A1 Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
04/17/2002EP1196640A2 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
04/17/2002EP1196412A1 Nitrogen containing heterobicycles as factor xa inhibitors
04/17/2002EP1196411A1 Bradykinin b1 receptor antagonists
04/17/2002EP1196408A1 Respiratory syncytial virus replication inhibitors
04/17/2002EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors
04/17/2002EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
04/17/2002EP1196392A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof
04/17/2002EP1196391A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors
04/17/2002EP1196390A2 Pyrazole compositions useful as inhibitors of erk
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002EP1196380A2 Indoles and indazoles for the treatment of migraine
04/17/2002EP1196166A1 Azetidine carboxamide derivatives for the treatment of cns disorders
04/17/2002EP1028730B1 Compositions of lipid lowering agents
04/17/2002EP0866792B1 Process for preparing a crystalline polymorph of terazosin hydrochloride
04/17/2002EP0831911B1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
04/17/2002CN1345319A Triazole compounds with dopamine-D3-receptor affinity
04/17/2002CN1345318A Triazole compounds with dopamine -D3-receptor affinity
04/17/2002CN1345314A Amine derivatives as protease inhibitors
04/17/2002CN1345311A 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivatives for treatment of CNS disorders
04/17/2002CN1345304A Substituted aniline compounds
04/17/2002CN1345242A Method for treatment of leukaemia
04/17/2002CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method
04/17/2002CN1082961C Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal and applications as medicine and pharmaceutical compositions thereof
04/16/2002US6372778 Sulfonamide inhibitors of aspartyl protease
04/16/2002US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles
04/16/2002US6372767 Benzanilides as potassium channel openers
04/16/2002US6372764 Pyrrolidine modulators of chemokine receptor activity
04/16/2002US6372762 Heterocyclic compounds for nervous system disorders
04/16/2002US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor
04/16/2002US6372752 Enzyme inhibitors, respiratory system disorders, tuberculosis and mycobacterium bactericides
04/16/2002US6372746 Derivatives of acyl-piperazinyl-pyrimidines, preparation thereof and application as medicaments
04/16/2002US6372739 Coumarone derivatives for drugs
04/16/2002CA2218552C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/16/2002CA2217601C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/16/2002CA2162710C Dyes designed for high sensitivity detection of double-stranded dna
04/16/2002CA2143252C Benzodioxanes derivatives; process for preparing the same and pharmaceutical compositions containing them
04/16/2002CA2088980C Pro-drugs for cck antagonists
04/11/2002WO2002028850A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells